
Coastal Financial Corporation (CCB) came out with quarterly earnings of $0.78 per share, missing the Zacks Consensus Estimate of $1.02 per share. This compares to earnings of $0.63 per share a year ago.
Coastal Financial Corporation is the banking holding company for Coastal Community Bank offering various banking products and services to small and medium-sized businesses, professionals and individuals in the Puget Sound region of Washington. The company is headquartered in Everett, Washington.
| Revenue (TTM) | $363.32M |
| Gross Profit (TTM) | $363.32M |
| EBITDA | — |
| Operating Margin | 15.50% |
| Return on Equity | 10.30% |
| Return on Assets | 0.99% |
| Revenue/Share (TTM) | $24.05 |
| Book Value | $33.05 |
| Price-to-Book | 2.38 |
| Price-to-Sales (TTM) | 3.27 |
| EV/Revenue | 3.056 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 23.80% |
| Quarterly Revenue Growth (YoY) | 17.00% |
| Shares Outstanding | $15.25M |
| Float | $13.17M |
| % Insiders | 15.28% |
| % Institutions | 86.35% |
Volatility is currently contracting

Coastal Financial Corporation (CCB) came out with quarterly earnings of $0.78 per share, missing the Zacks Consensus Estimate of $1.02 per share. This compares to earnings of $0.63 per share a year ago.

Coastal Financial (CCB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Sierra Bancorp (BSRR) came out with quarterly earnings of $0.96 per share, beating the Zacks Consensus Estimate of $0.82 per share. This compares to earnings of $0.65 per share a year ago.

Modine Manufacturing led the way during the quarter, benefiting from secular demand in data center cooling and a well received spinoff of Modine Manufacturing's auto cooling business. Coming out of 2025, Adeia reported record revenue and profitability, supported by a surge in IP licensing activity. AtriCure remains well positioned given its first-mover advantage and deep integration within surgical workflows despite near-term competitive concerns from Edwards Lifesciences.